Cocrystal Pharma (COCP) Stock Price, Quote, News & History

Comments

Cocrystal Pharma Inc (COCP) Stock Price, Quote, News & History

COCPNASDAQ

Trade with Public

$1.50

-0.01-0.66%

At close: Apr 6, 5:00 PM EST

$1.50

N/A

After Hours: 6:09 PM EST

PRO

Why Is It Moving?™:Why Cocrystal Pharma Shares Are Cooling Off Monday?

Earnings: Q4 2025 Earnings were released on Tue Mar 31st, before the market open

OverviewNews Earnings Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$1.49

Close

$1.50

Volume / Avg.

4.29M / 2.24M

Day Range

$1.34 - $1.52

52 Wk Range

0.86 - 2.67

Market Cap

$20.68M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

71

Short Interest

1.88%

Days to Cover

6.17

Recent Cocrystal Pharma Inc News

Why Cocrystal Pharma Shares Are Cooling Off Monday?

COCP stock is trading lower Monday morning. Learn why Cocrystal Pharma is seeing a pullback after receiving FDA Fast Track designation for CDI-988.

Kaustubh Bagalkote

Cocrystal Pharma Shares Soar After FDA Grants Fast Track Status To CDI-988

Cocrystal Pharma Inc. (NASDAQ:COCP) shares are trading higher Thursday after it received Fast Track designation from the FDA for its CDI-988.

Dylan Berman

Toll Brothers To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-8.19M

Investing Cash Flow (TTM)

-12.00K

Financing Cash Flow (TTM)

5.37M

Free Cash Flow (TTM)

-8.20M

Capital Expenditure (TTM)

-12.00K

Net Change in Cash (TTM)

-2.84M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$15.30M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

3.29

Earnings Yield % (TTM)

-51.65%

Earnings Yield % (FWD)

-64.23%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.46

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$7.03M

Debt to Equity

0.24

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.49

Close

$1.50

Volume / Avg.

4.29M / 2.24M

Day Range

$1.34 - $1.52

52 Wk Range

0.86 - 2.67

Market Cap

$20.68M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

71

Short Interest

1.88%

Days to Cover

6.17

About

Sector

Health Care

Industry

Pharmaceuticals

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobe...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Cocrystal Pharma (COCP) stock?

A

You can purchase shares of Cocrystal Pharma (NASDAQ:COCP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cocrystal Pharma (COCP) competitors?

A

Other companies in Cocrystal Pharma’s space includes: Lipocine Inc (NASDAQ:LPCN), VYNE Therapeutics Inc (NASDAQ:VYNE), Tvardi Therapeutics Inc (NASDAQ:TVRD), Traws Pharma Inc (NASDAQ:TRAW) and Cadrenal Therapeutics Inc (NASDAQ:CVKD).

Q

What is the forecast, or price target, for Cocrystal Pharma (COCP) stock?

A

Cocrystal Pharma has a consensus price target of $6.00.

Q

What is the current price for Cocrystal Pharma (COCP)?

A

The stock price for Cocrystal Pharma (NASDAQ: COCP) is $1.5 last updated April 6, 2026 at 6:09 PM EDT.

Q

Does Cocrystal Pharma (COCP) pay a dividend?

A

There are no upcoming dividends for Cocrystal Pharma.

Q

When is Cocrystal Pharma (NASDAQ:COCP) reporting earnings?

A

Cocrystal Pharma does not have any upcoming earnings scheduled.

Q

Is Cocrystal Pharma (COCP) going to split?

A

There is no upcoming split for Cocrystal Pharma.

Q

What sector and industry does Cocrystal Pharma (COCP) operate in?

A

Cocrystal Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

VYNE Therapeutics Inc

NASDAQ:VYNE

$0.61

0.21%

Tvardi Therapeutics Inc

Cadrenal Therapeutics Inc

XORTX Therapeutics Inc

NASDAQ:XRTX

$2.33

0.43%

Key Statistics

Open

$1.49

Close

$1.50

Volume / Avg.

4.29M / 2.24M

Day Range

$1.34 - $1.52

52 Wk Range

0.86 - 2.67

Market Cap

$20.68M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

71

Short Interest

1.88%

Days to Cover

6.17

Recent Cocrystal Pharma Inc News

Why Cocrystal Pharma Shares Are Cooling Off Monday?

COCP stock is trading lower Monday morning. Learn why Cocrystal Pharma is seeing a pullback after receiving FDA Fast Track designation for CDI-988.

Kaustubh Bagalkote

Cocrystal Pharma Shares Soar After FDA Grants Fast Track Status To CDI-988

Cocrystal Pharma Inc. (NASDAQ:COCP) shares are trading higher Thursday after it received Fast Track designation from the FDA for its CDI-988.

Dylan Berman

Toll Brothers To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-8.19M

Investing Cash Flow (TTM)

-12.00K

Financing Cash Flow (TTM)

5.37M

Free Cash Flow (TTM)

-8.20M

Capital Expenditure (TTM)

-12.00K

Net Change in Cash (TTM)

-2.84M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$15.30M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

3.29

Earnings Yield % (TTM)

-51.65%

Earnings Yield % (FWD)

-64.23%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.46

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$7.03M

Debt to Equity

0.24

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.49

Close

$1.50

Volume / Avg.

4.29M / 2.24M

Day Range

$1.34 - $1.52

52 Wk Range

0.86 - 2.67

Market Cap

$20.68M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

71

Short Interest

1.88%

Days to Cover

6.17

About

Sector

Health Care

Industry

Pharmaceuticals

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobe...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry